Late Presenters in New HIV Diagnoses from An Italian Cohort of HIV-Infected Patients: Prevalence and Clinical Outcome

Núñez M. , Asencio R. , Valencia M. , Leal M. , González-Lahoz J. , Soriano V. Rate, causes, and clinical implications of presenting with low CD4⁺ cell counts in the era of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2003; 19: 363–368.

Easterbrook P.J. , Yu L. , Goetghebeur E. , Boag F. , McLean K. , Gazzard B. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. AIDS 2000; 14: 561–571.

Girardi E. , Aloisi M. , Arici C. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004; 36: 951–959.

Mocroft A. , Phillips A. , Gatell J. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 2007; 370: 407–413.

Kelley C.F. , Kitchen C. , Hunt P. Incomplete peripheral CD4⁺ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis 2009; 48: 787–794.

Egger M. , May M. , Chêne G. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360: 119–129.

Kaufmann G.R. , Perrin L. , Pantaleo G. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med 2003; 163: 2187–2195.

Smith C.J. , Olsen C. , Mocroft A. The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study. AIDS 2008; 22: 47–56.

Curkendall S.M. , Richardson J. , Emons M. , Fisher A. , Everhard F. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy. HIV Med 2007; 8: 483–490.

Jericó C. , Knobel H. , Montero M. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care 2005; 28: 132–137.

Elzi L. , Marzolini C. , Furrer H. Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Arch Intern Med 2010; 170: 57–65.

Marks G. , Crepaz N. , Janssen R. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20: 1447–1450.

Crepaz N. , Marks G. , Liau A. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis. AIDS 2009; 23: 1617–1629.

Metsch L.R. , Pereyra M. , Messinger S. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis 2008; 47: 577–584.

Krentz H.B. , Auld M. , Gill M. The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med 2004; 5: 93–98.

Manavi K. , McMillan A. , Ogilvie M. , Scott G. Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Int J STD AIDS 2004; 15: 811–814.

Gay C.L. , Napravnik S. , Eron J.J. Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors. AIDS 2006; 20: 775–778.

Sabin C.A. , Smith C. , Gumley H. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 2004; 18: 2145–2151.

Castilla J. , Sobrino P. , De La Fuente L. , Noguer I. , Guerra L. , Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002; 16: 1945–1951.

Antinori A. , Johnson M. , Moreno S. , Yazdanpanah Y. , Rockstroh J.K. Report of a European Working Group on late presentation with HIV infection: recommendations and regional variation. Antivir Ther 2010; 15 Suppl 1: 31–35.

Antinori A. , Coenen T. , Dedes N. Late presentation of HIV infection: a consensus definition. HIV Medicine 2011; 12: 61–64.

When To Start Consortium. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373: 1352–1363.

Kitahata M.M. , Gange S. , Abraham A. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360: 1815–1826.

Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. (Updated 10 January 2011. Accessed 3 November 2010.) Available from http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf.

EACS. Guidelines for clinical management and treatment of HIV infected adults in Europe. (Accessed 3 November 2010.) Available from http://europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/1_treatment_of_hiv_infected_adults.pdf.

d'Arminio Monforte A. , Lepri A. , Rezza G. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients. AIDS 2000; 14: 499–507.

Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41: 1–19.

Wolbers M. , Bucher H. , Furrer H. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med 2008; 9: 397–405.

Delpierre C. , Lauwers-Cances V. , Pugliese P. Characteristics trends, mortality and morbidity in persons newly diagnosed HIV positive during the last decade: the profile of new HIV diagnosed people. Eur J Public Health 2008; 18: 345–347.

Begovac J. , Gedike K. , Lukas D. , Lepej S. Late presentation to care for HIV infection in Croatia and the effect of interventions during the Croatian Global Fund Project. AIDS Behav 2008; 12: S48–S53.

Sullivan A.K. , Curtis H. , Sabin C. , Johnson M. Newly diagnosed HIV infections: review in UK and Ireland. BMJ 2005; 330: 1301–1302.

Borghi V. , Girardi E. , Bellelli S. Late presenters in an HIV surveillance system in Italy during the period 1992-2006. J Acquir Immune Defic Syndr 2008; 49: 282–286.

The UK Collaborative HIV Cohort (UK CHIC) Steering Committee. Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS 2010; 24: 723–727.

Lanoy E. , Mary-Krause M. , Tattevin P. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 2007; 12: 89–96.

Quinn T.C. , Wawer M. , Sewankambo N. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342: 921–929.

Zolopa A. , Andersen J. , Powderly W. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE 2009; 4: e5575.

Chadborn T.R. , Delpech V. , Sabin C. , Sinka K. , Evans B. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS 2006; 20: 2371–2379.

Chadborn T.R. , Baster K. , Delpech V. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002). AIDS 2005; 19: 513–520.

Smit C. , Hallett T. , Lange J. , Garnett G. , de Wolf F. Late entry to HIV care limits the impact of anti-retroviral therapy in the Netherlands. PLoS One 2008; 3: e1949.

The antiretroviral therapy cohort collaboration (ART-CC). Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements. AIDS 2009; 23: 2199–2208.

Guiguet M. , Kendjo E. , Carcelain G. CD4⁺ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4⁺ T-cell counts >200 cells/mm³. Antivir Ther 2009; 14: 451–457.

Ray K. , Gupta S. , Bala M. , Muralidhar S. , Kumar J. CD4/CD8 lymphocyte counts in healthy, HIV-positive individuals & AIDS patients. Indian J Med Res 2006; 124: 319–330.

Anderson R.E. , Shiboski S. , Royce R. , Jewell N. , Lang W. , Winkelstein W.J. CD8⁺ T lymphocytes and progression to AIDS in HIV-infected men: some observations. AIDS 1991; 5: 213–215.

Chevret S. , Roquin H. , Ganne P. , Lefrère J. Prognostic value of an elevated CD8 lymphocyte count in HIV infection. Results of a prospective study of 152 asymptomatic HIV-positive individuals. AIDS 1992; 6: 1349–1352.

Reus S. , Portilla J. , Gimeno A. Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy. Enferm Infecc Microbiol Clin 2004; 22: 142–149.

Prosperi M.C.F. , Cozzi-Lepri A. , Castagna A. The incidence of malignancies in HIV-infected patients and postic role of current CD4 cell count: evidence from a Italian study. Clin Infect Dis 2010; 50: 1316–1321.